Home
About
Overview
Sharing Data
ORCID
Help
History (27)
Principal Investigator
Contraindications, Drug
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease.
Increase in short-term risk of rejection in heart transplant patients receiving granulocyte colony-stimulating factor.
Co-Principal Investigator
See All 27 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Co-Principal Investigator
Overview
researcher role of
Li, Yan
contributes to
Novel drug VS-105 for treatment of diabetic nephropathy